Retatrutide 40mg

Retatrutide is an investigational triple-receptor peptide developed to engage GLP-1, GIP and glucagon receptor pathways. Laboratory interest centers on the interaction of these three metabolic signaling systems and how combined receptor activity differs from single- or dual-incretin models.

The 40mg format is the highest-strength Retatrutide option in the current Kelden Peptide Sciences Canada catalog, allowing projects that require a larger total amount of the same research compound while maintaining the same underlying molecular identity.

For larger orders, visit our wholesale page to enquire about quantity pricing and availability. Include the product name and required quantity with your enquiry.

Request Wholesale Pricing